Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · IEX Real-Time Price · USD
3.200
+0.050 (1.59%)
Apr 26, 2024, 4:30 PM EDT - Market closed
Repare Therapeutics Stock Forecast
RPTX's stock price has decreased by -65.62% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Repare Therapeutics stock have an average target of 17.33, with a low estimate of 10 and a high estimate of 25. The average target predicts an increase of 441.56% from the current stock price of 3.20.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 8, 2024.
Analyst Ratings
The average analyst rating for RPTX stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +212.50% | Mar 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +212.50% | Feb 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $10 | Strong Buy | Maintains | $25 → $10 | +212.50% | Feb 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +681.25% | Nov 20, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $30 → $25 | Buy | Maintains | $30 → $25 | +681.25% | Oct 16, 2023 |
Financial Forecast
Revenue This Year
46.88M
from 51.13M
Decreased by -8.33%
Revenue Next Year
28.39M
from 46.88M
Decreased by -39.43%
EPS This Year
-2.71
from -2.23
EPS Next Year
-3.44
from -2.71
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 52.5M | 52.5M | 84.4M | 196.6M | 346.1M |
| Avg | 28.4M | 29.0M | 34.2M | 91.9M | 247.5M |
| Low | 19.6M | n/a | 9.8M | 24.9M | 152.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.7% | 84.9% | 190.8% | 474.3% | 276.6% |
| Avg | -44.5% | 2.2% | 17.9% | 168.5% | 169.3% |
| Low | -61.7% | - | -66.2% | -27.3% | 65.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.08 | -2.56 | -2.90 | -0.82 | 0.83 |
| Avg | -3.44 | -3.18 | -3.29 | -1.91 | 0.81 |
| Low | -3.96 | -3.47 | -3.62 | -2.90 | 0.77 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.